Global Nitinol-based Stent Market Research Report 2023

Publisher Name :
Date: 15-Nov-2023
No. of pages: 103
Inquire Before Buying

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Nitinol-based Stent market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

By Company

- Medtronic

- Edwards Lifesciences

- Abbott

- Boston Scientific

- TERUMO

- C. R. Bard

- Cordis

- Cook Medical

- B. Braun

- Biotronik

- Stryker

- JOTEC

- MicroPort

- Acandis

- ELLA-CS

Segment by Type

- Bare-metal Stent (BMS)

- Drug-eluting Stent (DES)

Segment by Application

- Hospital

- Clinics

- Other

Consumption by Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

The Nitinol-based Stent report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Manufacturers' Competition Patterns

Chapter 3: Country Level Sales Analysis

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6: Manufacturers' Outline

Chapter 7: Industry Chain, Market Channel and Customer Analysis

Chapter 8: Market Opportunities and Challenges

Chapter 9: Market Conclusions

Chapter 10: Research Methodology and Data Source

Global Nitinol-based Stent Market Research Report 2023

Table of Contents
1 Nitinol-based Stent Market Overview
1.1 Product Overview and Scope of Nitinol-based Stent
1.2 Nitinol-based Stent Segment by Type
1.2.1 Global Nitinol-based Stent Market Value Comparison by Type (2023-2029)
1.2.2 Bare-metal Stent (BMS)
1.2.3 Drug-eluting Stent (DES)
1.3 Nitinol-based Stent Segment by Application
1.3.1 Global Nitinol-based Stent Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Other
1.4 Global Nitinol-based Stent Market Size Estimates and Forecasts
1.4.1 Global Nitinol-based Stent Revenue 2018-2029
1.4.2 Global Nitinol-based Stent Sales 2018-2029
1.4.3 Global Nitinol-based Stent Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nitinol-based Stent Market Competition by Manufacturers
2.1 Global Nitinol-based Stent Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nitinol-based Stent Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nitinol-based Stent Average Price by Manufacturers (2018-2023)
2.4 Global Nitinol-based Stent Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nitinol-based Stent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nitinol-based Stent, Product Type & Application
2.7 Nitinol-based Stent Market Competitive Situation and Trends
2.7.1 Nitinol-based Stent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nitinol-based Stent Players Market Share by Revenue
2.7.3 Global Nitinol-based Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nitinol-based Stent Retrospective Market Scenario by Region
3.1 Global Nitinol-based Stent Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nitinol-based Stent Global Nitinol-based Stent Sales by Region: 2018-2029
3.2.1 Global Nitinol-based Stent Sales by Region: 2018-2023
3.2.2 Global Nitinol-based Stent Sales by Region: 2024-2029
3.3 Global Nitinol-based Stent Global Nitinol-based Stent Revenue by Region: 2018-2029
3.3.1 Global Nitinol-based Stent Revenue by Region: 2018-2023
3.3.2 Global Nitinol-based Stent Revenue by Region: 2024-2029
3.4 North America Nitinol-based Stent Market Facts & Figures by Country
3.4.1 North America Nitinol-based Stent Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nitinol-based Stent Sales by Country (2018-2029)
3.4.3 North America Nitinol-based Stent Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Nitinol-based Stent Market Facts & Figures by Country
3.5.1 Europe Nitinol-based Stent Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nitinol-based Stent Sales by Country (2018-2029)
3.5.3 Europe Nitinol-based Stent Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nitinol-based Stent Market Facts & Figures by Country
3.6.1 Asia Pacific Nitinol-based Stent Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nitinol-based Stent Sales by Country (2018-2029)
3.6.3 Asia Pacific Nitinol-based Stent Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nitinol-based Stent Market Facts & Figures by Country
3.7.1 Latin America Nitinol-based Stent Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nitinol-based Stent Sales by Country (2018-2029)
3.7.3 Latin America Nitinol-based Stent Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nitinol-based Stent Market Facts & Figures by Country
3.8.1 Middle East and Africa Nitinol-based Stent Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nitinol-based Stent Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nitinol-based Stent Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nitinol-based Stent Sales by Type (2018-2029)
4.1.1 Global Nitinol-based Stent Sales by Type (2018-2023)
4.1.2 Global Nitinol-based Stent Sales by Type (2024-2029)
4.1.3 Global Nitinol-based Stent Sales Market Share by Type (2018-2029)
4.2 Global Nitinol-based Stent Revenue by Type (2018-2029)
4.2.1 Global Nitinol-based Stent Revenue by Type (2018-2023)
4.2.2 Global Nitinol-based Stent Revenue by Type (2024-2029)
4.2.3 Global Nitinol-based Stent Revenue Market Share by Type (2018-2029)
4.3 Global Nitinol-based Stent Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nitinol-based Stent Sales by Application (2018-2029)
5.1.1 Global Nitinol-based Stent Sales by Application (2018-2023)
5.1.2 Global Nitinol-based Stent Sales by Application (2024-2029)
5.1.3 Global Nitinol-based Stent Sales Market Share by Application (2018-2029)
5.2 Global Nitinol-based Stent Revenue by Application (2018-2029)
5.2.1 Global Nitinol-based Stent Revenue by Application (2018-2023)
5.2.2 Global Nitinol-based Stent Revenue by Application (2024-2029)
5.2.3 Global Nitinol-based Stent Revenue Market Share by Application (2018-2029)
5.3 Global Nitinol-based Stent Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Corporation Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Medtronic Nitinol-based Stent Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Edwards Lifesciences
6.2.1 Edwards Lifesciences Corporation Information
6.2.2 Edwards Lifesciences Description and Business Overview
6.2.3 Edwards Lifesciences Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Edwards Lifesciences Nitinol-based Stent Product Portfolio
6.2.5 Edwards Lifesciences Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Nitinol-based Stent Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Boston Scientific
6.4.1 Boston Scientific Corporation Information
6.4.2 Boston Scientific Description and Business Overview
6.4.3 Boston Scientific Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boston Scientific Nitinol-based Stent Product Portfolio
6.4.5 Boston Scientific Recent Developments/Updates
6.5 TERUMO
6.5.1 TERUMO Corporation Information
6.5.2 TERUMO Description and Business Overview
6.5.3 TERUMO Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.5.4 TERUMO Nitinol-based Stent Product Portfolio
6.5.5 TERUMO Recent Developments/Updates
6.6 C. R. Bard
6.6.1 C. R. Bard Corporation Information
6.6.2 C. R. Bard Description and Business Overview
6.6.3 C. R. Bard Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.6.4 C. R. Bard Nitinol-based Stent Product Portfolio
6.6.5 C. R. Bard Recent Developments/Updates
6.7 Cordis
6.6.1 Cordis Corporation Information
6.6.2 Cordis Description and Business Overview
6.6.3 Cordis Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Cordis Nitinol-based Stent Product Portfolio
6.7.5 Cordis Recent Developments/Updates
6.8 Cook Medical
6.8.1 Cook Medical Corporation Information
6.8.2 Cook Medical Description and Business Overview
6.8.3 Cook Medical Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Cook Medical Nitinol-based Stent Product Portfolio
6.8.5 Cook Medical Recent Developments/Updates
6.9 B. Braun
6.9.1 B. Braun Corporation Information
6.9.2 B. Braun Description and Business Overview
6.9.3 B. Braun Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.9.4 B. Braun Nitinol-based Stent Product Portfolio
6.9.5 B. Braun Recent Developments/Updates
6.10 Biotronik
6.10.1 Biotronik Corporation Information
6.10.2 Biotronik Description and Business Overview
6.10.3 Biotronik Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Biotronik Nitinol-based Stent Product Portfolio
6.10.5 Biotronik Recent Developments/Updates
6.11 Stryker
6.11.1 Stryker Corporation Information
6.11.2 Stryker Nitinol-based Stent Description and Business Overview
6.11.3 Stryker Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Stryker Nitinol-based Stent Product Portfolio
6.11.5 Stryker Recent Developments/Updates
6.12 JOTEC
6.12.1 JOTEC Corporation Information
6.12.2 JOTEC Nitinol-based Stent Description and Business Overview
6.12.3 JOTEC Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.12.4 JOTEC Nitinol-based Stent Product Portfolio
6.12.5 JOTEC Recent Developments/Updates
6.13 MicroPort
6.13.1 MicroPort Corporation Information
6.13.2 MicroPort Nitinol-based Stent Description and Business Overview
6.13.3 MicroPort Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.13.4 MicroPort Nitinol-based Stent Product Portfolio
6.13.5 MicroPort Recent Developments/Updates
6.14 Acandis
6.14.1 Acandis Corporation Information
6.14.2 Acandis Nitinol-based Stent Description and Business Overview
6.14.3 Acandis Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Acandis Nitinol-based Stent Product Portfolio
6.14.5 Acandis Recent Developments/Updates
6.15 ELLA-CS
6.15.1 ELLA-CS Corporation Information
6.15.2 ELLA-CS Nitinol-based Stent Description and Business Overview
6.15.3 ELLA-CS Nitinol-based Stent Sales, Revenue and Gross Margin (2018-2023)
6.15.4 ELLA-CS Nitinol-based Stent Product Portfolio
6.15.5 ELLA-CS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nitinol-based Stent Industry Chain Analysis
7.2 Nitinol-based Stent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nitinol-based Stent Production Mode & Process
7.4 Nitinol-based Stent Sales and Marketing
7.4.1 Nitinol-based Stent Sales Channels
7.4.2 Nitinol-based Stent Distributors
7.5 Nitinol-based Stent Customers
8 Nitinol-based Stent Market Dynamics
8.1 Nitinol-based Stent Industry Trends
8.2 Nitinol-based Stent Market Drivers
8.3 Nitinol-based Stent Market Challenges
8.4 Nitinol-based Stent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Nitinol-based Stent Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Nitinol-based Stent Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Nitinol-based Stent Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nitinol-based Stent Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Nitinol-based Stent Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Nitinol-based Stent Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Nitinol-based Stent Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Nitinol-based Stent Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Nitinol-based Stent, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Nitinol-based Stent, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nitinol-based Stent, Product Type & Application
Table 12. Global Key Manufacturers of Nitinol-based Stent, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nitinol-based Stent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nitinol-based Stent as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nitinol-based Stent Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nitinol-based Stent Sales by Region (2018-2023) & (K Units)
Table 18. Global Nitinol-based Stent Sales Market Share by Region (2018-2023)
Table 19. Global Nitinol-based Stent Sales by Region (2024-2029) & (K Units)
Table 20. Global Nitinol-based Stent Sales Market Share by Region (2024-2029)
Table 21. Global Nitinol-based Stent Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Nitinol-based Stent Revenue Market Share by Region (2018-2023)
Table 23. Global Nitinol-based Stent Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nitinol-based Stent Revenue Market Share by Region (2024-2029)
Table 25. North America Nitinol-based Stent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 27. North America Nitinol-based Stent Sales by Country (2024-2029) & (K Units)
Table 28. North America Nitinol-based Stent Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Nitinol-based Stent Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nitinol-based Stent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 32. Europe Nitinol-based Stent Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nitinol-based Stent Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Nitinol-based Stent Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nitinol-based Stent Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nitinol-based Stent Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Nitinol-based Stent Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nitinol-based Stent Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Nitinol-based Stent Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nitinol-based Stent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Nitinol-based Stent Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nitinol-based Stent Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Nitinol-based Stent Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nitinol-based Stent Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nitinol-based Stent Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Nitinol-based Stent Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nitinol-based Stent Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Nitinol-based Stent Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nitinol-based Stent Sales (K Units) by Type (2018-2023)
Table 51. Global Nitinol-based Stent Sales (K Units) by Type (2024-2029)
Table 52. Global Nitinol-based Stent Sales Market Share by Type (2018-2023)
Table 53. Global Nitinol-based Stent Sales Market Share by Type (2024-2029)
Table 54. Global Nitinol-based Stent Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Nitinol-based Stent Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nitinol-based Stent Revenue Market Share by Type (2018-2023)
Table 57. Global Nitinol-based Stent Revenue Market Share by Type (2024-2029)
Table 58. Global Nitinol-based Stent Price (US$/Unit) by Type (2018-2023)
Table 59. Global Nitinol-based Stent Price (US$/Unit) by Type (2024-2029)
Table 60. Global Nitinol-based Stent Sales (K Units) by Application (2018-2023)
Table 61. Global Nitinol-based Stent Sales (K Units) by Application (2024-2029)
Table 62. Global Nitinol-based Stent Sales Market Share by Application (2018-2023)
Table 63. Global Nitinol-based Stent Sales Market Share by Application (2024-2029)
Table 64. Global Nitinol-based Stent Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Nitinol-based Stent Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nitinol-based Stent Revenue Market Share by Application (2018-2023)
Table 67. Global Nitinol-based Stent Revenue Market Share by Application (2024-2029)
Table 68. Global Nitinol-based Stent Price (US$/Unit) by Application (2018-2023)
Table 69. Global Nitinol-based Stent Price (US$/Unit) by Application (2024-2029)
Table 70. Medtronic Corporation Information
Table 71. Medtronic Description and Business Overview
Table 72. Medtronic Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Medtronic Nitinol-based Stent Product
Table 74. Medtronic Recent Developments/Updates
Table 75. Edwards Lifesciences Corporation Information
Table 76. Edwards Lifesciences Description and Business Overview
Table 77. Edwards Lifesciences Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Edwards Lifesciences Nitinol-based Stent Product
Table 79. Edwards Lifesciences Recent Developments/Updates
Table 80. Abbott Corporation Information
Table 81. Abbott Description and Business Overview
Table 82. Abbott Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Abbott Nitinol-based Stent Product
Table 84. Abbott Recent Developments/Updates
Table 85. Boston Scientific Corporation Information
Table 86. Boston Scientific Description and Business Overview
Table 87. Boston Scientific Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Boston Scientific Nitinol-based Stent Product
Table 89. Boston Scientific Recent Developments/Updates
Table 90. TERUMO Corporation Information
Table 91. TERUMO Description and Business Overview
Table 92. TERUMO Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. TERUMO Nitinol-based Stent Product
Table 94. TERUMO Recent Developments/Updates
Table 95. C. R. Bard Corporation Information
Table 96. C. R. Bard Description and Business Overview
Table 97. C. R. Bard Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. C. R. Bard Nitinol-based Stent Product
Table 99. C. R. Bard Recent Developments/Updates
Table 100. Cordis Corporation Information
Table 101. Cordis Description and Business Overview
Table 102. Cordis Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Cordis Nitinol-based Stent Product
Table 104. Cordis Recent Developments/Updates
Table 105. Cook Medical Corporation Information
Table 106. Cook Medical Description and Business Overview
Table 107. Cook Medical Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Cook Medical Nitinol-based Stent Product
Table 109. Cook Medical Recent Developments/Updates
Table 110. B. Braun Corporation Information
Table 111. B. Braun Description and Business Overview
Table 112. B. Braun Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. B. Braun Nitinol-based Stent Product
Table 114. B. Braun Recent Developments/Updates
Table 115. Biotronik Corporation Information
Table 116. Biotronik Description and Business Overview
Table 117. Biotronik Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Biotronik Nitinol-based Stent Product
Table 119. Biotronik Recent Developments/Updates
Table 120. Stryker Corporation Information
Table 121. Stryker Description and Business Overview
Table 122. Stryker Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Stryker Nitinol-based Stent Product
Table 124. Stryker Recent Developments/Updates
Table 125. JOTEC Corporation Information
Table 126. JOTEC Description and Business Overview
Table 127. JOTEC Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. JOTEC Nitinol-based Stent Product
Table 129. JOTEC Recent Developments/Updates
Table 130. MicroPort Corporation Information
Table 131. MicroPort Description and Business Overview
Table 132. MicroPort Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. MicroPort Nitinol-based Stent Product
Table 134. MicroPort Recent Developments/Updates
Table 135. Acandis Corporation Information
Table 136. Acandis Description and Business Overview
Table 137. Acandis Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Acandis Nitinol-based Stent Product
Table 139. Acandis Recent Developments/Updates
Table 140. ELLA-CS Corporation Information
Table 141. ELLA-CS Description and Business Overview
Table 142. ELLA-CS Nitinol-based Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. ELLA-CS Nitinol-based Stent Product
Table 144. ELLA-CS Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Nitinol-based Stent Distributors List
Table 148. Nitinol-based Stent Customers List
Table 149. Nitinol-based Stent Market Trends
Table 150. Nitinol-based Stent Market Drivers
Table 151. Nitinol-based Stent Market Challenges
Table 152. Nitinol-based Stent Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nitinol-based Stent
Figure 2. Global Nitinol-based Stent Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Nitinol-based Stent Market Share by Type in 2022 & 2029
Figure 4. Bare-metal Stent (BMS) Product Picture
Figure 5. Drug-eluting Stent (DES) Product Picture
Figure 6. Global Nitinol-based Stent Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Nitinol-based Stent Market Share by Application in 2022 & 2029
Figure 8. Hospital
Figure 9. Clinics
Figure 10. Other
Figure 11. Global Nitinol-based Stent Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Nitinol-based Stent Market Size (2018-2029) & (US$ Million)
Figure 13. Global Nitinol-based Stent Sales (2018-2029) & (K Units)
Figure 14. Global Nitinol-based Stent Average Price (US$/Unit) & (2018-2029)
Figure 15. Nitinol-based Stent Report Years Considered
Figure 16. Nitinol-based Stent Sales Share by Manufacturers in 2022
Figure 17. Global Nitinol-based Stent Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Nitinol-based Stent Players: Market Share by Revenue in 2022
Figure 19. Nitinol-based Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Nitinol-based Stent Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Nitinol-based Stent Sales Market Share by Country (2018-2029)
Figure 22. North America Nitinol-based Stent Revenue Market Share by Country (2018-2029)
Figure 23. United States Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Nitinol-based Stent Sales Market Share by Country (2018-2029)
Figure 26. Europe Nitinol-based Stent Revenue Market Share by Country (2018-2029)
Figure 27. Germany Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Nitinol-based Stent Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Nitinol-based Stent Revenue Market Share by Region (2018-2029)
Figure 34. China Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Latin America Nitinol-based Stent Sales Market Share by Country (2018-2029)
Figure 44. Latin America Nitinol-based Stent Revenue Market Share by Country (2018-2029)
Figure 45. Mexico Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Brazil Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Argentina Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Nitinol-based Stent Sales Market Share by Country (2018-2029)
Figure 49. Middle East & Africa Nitinol-based Stent Revenue Market Share by Country (2018-2029)
Figure 50. Turkey Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. UAE Nitinol-based Stent Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Global Sales Market Share of Nitinol-based Stent by Type (2018-2029)
Figure 54. Global Revenue Market Share of Nitinol-based Stent by Type (2018-2029)
Figure 55. Global Nitinol-based Stent Price (US$/Unit) by Type (2018-2029)
Figure 56. Global Sales Market Share of Nitinol-based Stent by Application (2018-2029)
Figure 57. Global Revenue Market Share of Nitinol-based Stent by Application (2018-2029)
Figure 58. Global Nitinol-based Stent Price (US$/Unit) by Application (2018-2029)
Figure 59. Nitinol-based Stent Value Chain
Figure 60. Nitinol-based Stent Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs